Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2014 | 11-2013 | 08-2013 | 05-2013 | 02-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,269 | 1,387 | 2,288 | 1,121 | 2,056 |
| Marketable Securities | 20,098 | 6,422 | 6,203 | 3,127 | 3,305 |
| Receivables | 75 | 5 | 63 | 513 | 543 |
| TOTAL | $23,687 | $7,986 | $8,644 | $4,824 | $5,939 |
| Non-Current Assets | |||||
| PPE Net | 12 | 9 | 6 | 6 | 2 |
| Investments And Advances | 5 | 5 | 5 | 9 | 9 |
| Other Non-Current Assets | 6 | 6 | 6 | 7 | 7 |
| TOTAL | $23 | $19 | $16 | $23 | $18 |
| Total Assets | $23,710 | $8,006 | $8,660 | $4,846 | $5,957 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 350 | 669 | 498 | 446 | 469 |
| TOTAL | $350 | $669 | $498 | $446 | $469 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 32 | 31 | 241 | 240 |
| TOTAL | $32 | $32 | $31 | $241 | $240 |
| Total Liabilities | $382 | $700 | $529 | $687 | $709 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,943 | 9,745 | N/A | 7,901 | 7,223 |
| Common Shares | 117 | 95 | 95 | 87 | 87 |
| Retained earnings | -24,363 | -23,248 | -22,124 | -21,333 | -20,076 |
| Other shareholders' equity | 847 | 334 | 304 | 132 | 244 |
| TOTAL | $23,328 | $7,305 | $8,131 | $4,159 | $5,248 |
| Total Liabilities And Equity | $23,710 | $8,006 | $8,660 | $4,846 | $5,957 |